The new drug is the best evidence yet that biotech companies are likely to be drawn into the fight against bioterror, thanks to stripped-down U.S. regulations that make it easier to get drugs approved to treat diseases like anthrax and smallpox.

FORBES: Genomics Pioneer Takes On Anthrax

Yet keeping the smallpox around dramatically increases the risk that a deranged person will get his hands on it and release it in the population.

FORBES: It's time to destroy the U.S. smallpox reserves